Caught on Camera: Novo Nordisk Executive Collapses in Oval Office
Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon. This occurred during President Trump's announcement of a plan to reduce the price of weight-loss medications, including Ozempic.
Findlay received immediate medical assistance and was helped to his feet. Officials expect him to recover fully without complications.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
The incident was captured on camera, drawing attention while the administration discussed efforts to make weight-loss treatments more affordable.
Context and Additional Information
- President Trump unveiled new measures targeting drug prices, aiming to improve accessibility of weight-loss medications.
- Ozempic, a popular medication produced by Novo Nordisk, was specifically mentioned during the announcement.
Media Coverage
- Reported by Jodi Leese Glusco on November 6, 2025
- Additional news related to health, weather, and major events were shared alongside the coverage of the incident.
The sudden collapse of a key pharmaceutical executive highlighted the intensity and pressure surrounding this significant policy announcement.
Author’s summary: A Novo Nordisk executive fainted during President Trump's weight-loss drug price reduction announcement but is expected to recover, underscoring the event's high stakes.